Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age-Reference-Cited by-同舟云学术

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age

Published:2024-06-27 Issue:24 Volume:390 Page:2239-2251
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Chehade Mirna¹,Dellon Evan S.¹,Spergel Jonathan M.¹,Collins Margaret H.¹,Rothenberg Marc E.¹,Pesek Robert D.¹,Hirano Ikuo¹,Liu Ruiqi¹,Laws Elizabeth¹,Mortensen Eric¹,Martincova Renata¹,Shabbir Arsalan¹,McCann Eilish¹,Kamal Mohamed A.¹,Kosloski Matthew P.¹,Hamilton Jennifer D.¹,Samuely Carin¹,Lim Wei Keat¹,Wipperman Matthew F.¹^ORCID,Farrell Annamaria¹,Patel Naimish¹,Yancopoulos George D.¹,Glotfelty Lila¹,Maloney Jennifer¹

Affiliation:

1. From the Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York (M.C.), and Regeneron Pharmaceuticals, Tarrytown (R.L., E. Mortensen, A.S., E. McCann, M.A.K., M.P.K., J.D.H., C.S., W.K.L., M.F.W., A.F., G.D.Y., J.M.) — both in New York; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill (E.S.D.); the Division of Allergy and Immunology, Children’s...

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2312282

Reference36 articles.

1. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

3. Determinant factors of quality of life in adult patients with eosinophilic esophagitis

4. Eosinophilic Esophagitis

5. Epidemiology and Natural History of Eosinophilic Esophagitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. La pagina gialla;Medico e Bambino;2024-09-06

2. From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis;Biomolecules;2024-08-28

3. The role of dupilumab in the treatment of eosinophilic esophagitis;Immunotherapy;2024-07-29

4. Shifting targets for eosinophilic oesophagitis;Nature Reviews Gastroenterology & Hepatology;2024-07-22

5. Unmasking the Culprits in Eosinophilic Esophagitis Pathogenesis;New England Journal of Medicine;2024-06-27